FINGOLIMOD HYDROCHLORIDE | A207993 | APOTEX INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al 2 patentsANDA 207993, 210252, 207927, 207945, 207985, 207939, 207933, 208003, 207971, 207994Fingolimod | D. Del. | 2020-01-28 | Active | — |
| S.D. Fla. | 2015-10-28 | Terminated 2015-11-23 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.29
per ea
Lowest NADAC/Unit
$3.29
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 60505433203FINGOLIMOD 0.5 MG CAPSULE | $3.29 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.